Evidence map›Paper›PMID 35806696›Full record

ArticleMaterials (Basel, Switzerland)2022

Rosmarinic Acid-Loaded Polymeric Nanoparticles Prepared by Low-Energy Nano-Emulsion Templating: Formulation, Biophysical Characterization, and In Vitro Studies.

Jessica García-Melero, Joan-Josep López-Mitjavila, María José García-Celma, Carlos Rodriguez-Abreu, Santiago Grijalvo

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica García-MeleroInstitute for Advanced Chemistry of Catalonia (CSIC-IQAC), Jordi Girona 18-26, E-08034 Barcelona, Spain.ORCID 0000-0003-2434-6826
Joan-Josep López-MitjavilaInstitute for Advanced Chemistry of Catalonia (CSIC-IQAC), Jordi Girona 18-26, E-08034 Barcelona, Spain.
María José García-CelmaDepartment of Pharmacy, Pharmaceutical Technology, and Physical-Chemistry, R+D Associated Unit to CSIC Pharmaceutical Nanotechnology, IN2UB, University of Barcelona, Joan XXIII 27-31, E-08028 Barcelona, Spain.
Carlos Rodriguez-AbreuInstitute for Advanced Chemistry of Catalonia (CSIC-IQAC), Jordi Girona 18-26, E-08034 Barcelona, Spain.
Santiago GrijalvoNetworking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Jordi Girona 18-26, E-08034 Barcelona, Spain.ORCID 0000-0002-8405-4844

Funding

Centro de Investigación Biomédica en Red CB06/01/1058Spanish National Research Council CTQ2017-84998-P
6 · The paper itself

Abstract

Rosmarinic acid (RA), a caffeic acid derivative, has been loaded in polymeric nanoparticles made up of poly(lactic-

Indexed as

antioxidant activitycellular uptakecolloidal dispersionsdrug deliverynano-emulsionsnanoparticlesphytochemicalPLGAprotein corona

Identifiers

PMID35806696
PMCPMC9267406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.